BASF, Faces

BASF Faces a Double Squeeze as Buyback Expiry Meets Mounting Industry Pressures

Published on 06/19/2026 at 18:37 | Redaktion boerse-global.de

BASF's €1.5B buyback ends June 30, shifting focus to cost discipline via CoreShift program and €8.7B China complex as EBITDA target set at €6.2B-€7.0B for 2026.

BASF Buyback Pause: Cost Cuts and China Megaproject Take Center Stage
BASF Faces a Double Squeeze as Buyback Expiry Meets Mounting Industry Pressures Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

The clock is ticking on one of BASF's key shareholder support mechanisms. The initial €1.5 billion tranche of the chemicals giant's share buyback program winds down at the end of June, removing a steady source of demand that had been absorbing stock since last November. With roughly 31 million shares already repurchased and cancelled, the company now enters a period where operational performance alone must carry the weight.

Cost discipline is stepping into the breach. In May, BASF launched CoreShift, a transformation program targeting a 20% reduction in cash fixed costs across its core segments — Chemicals, Materials, Industrial Solutions, and Nutrition & Care — by 2029, relative to 2024 levels. Chief executive Markus Kamieth has described it as a "new operating system" for the group, though specific headcount implications remain under discussion with employee representatives. The predecessor program has already exceeded expectations, delivering annual savings of €1.7 billion by the end of 2025 — €100 million above target — and the company aims to push that figure to €2.3 billion by the end of this year.

The financial outlook is anchored in those internal efforts. For the full year 2026, BASF expects EBITDA before special items of between €6.2 billion and €7.0 billion, while free cash flow is projected at up to €2.3 billion. The first quarter provided a solid foundation, with earnings per share coming in at €1.06. Yet external conditions remain hostile. Germany's chemical industry association VCI forecasts flat production for 2026, with chemical output specifically falling 1% and potential revenue shrinking 3.5% amid declining prices.

Should investors sell immediately? Or is it worth buying BASF?

At the bourse, the stock reflects the tension. Trading at €48.92, BASF's shares sit roughly 11% below April's peak of €55.05, though they still show a year-to-date gain of about 9%. Technical signals have turned cautious: the shares recently slipped below their 100-day moving average, with the next support level waiting at the 200-day average around €47.08. The end of the buyback removes a structural bid that had been steadily mopping up excess paper.

Management has yet to outline a concrete timeline for the next tranche under the broader €4 billion buyback program running to 2028 — a gap that heightens the spotlight on organic drivers. BASF is betting heavily on its sprawling Zhanjiang complex in China, where around €8.7 billion has been invested. The first integrated value chains, including a steam cracker that was ramped up in record time, began operations at the turn of the year. Whether that megaproject combined with aggressive cost-cutting can compensate for the lost buyback momentum is a question that will likely be answered when second-quarter results land in the autumn.

Ad

BASF Stock: New Analysis - 19 June

Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated BASF analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | DE000BASF111 | BASF | boerse | 69584246 |